| abstract |
The present disclosure provides a phosphatidylinositol 3-kinase (PI3K) inhibitor of formula J, or a pharmaceutically acceptable salt thereof. These compounds are useful for the treatment of conditions mediated by one or more PI3K isoforms. The present disclosure further provides pharmaceutical compositions comprising a compound of formula J or a pharmaceutically acceptable salt thereof and methods of using these compounds and compositions for treating conditions mediated by one or more PI3K isoforms . <Formula J> Wherein A, n, m, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are as defined herein. |